08:00 , Nov 3, 2014 |  BC Week In Review  |  Company News

Osiris, Arthrex deal

Osiris granted Arthrex exclusive development and commercialization rights to Cartiform . Osiris will be responsible for the manufacturing, continued research and product improvement, though the companies will share responsibilities related to the design and conduct...
07:00 , Aug 19, 2013 |  BC Week In Review  |  Company News

Arthrex Inc., Cytomedix deal

Cytomedix granted orthopedic device company Arthrex exclusive, worldwide development and commercialization rights to Cytomedix's Angel Concentrated Platelet Rich Plasma System for five years, with a three year renewal option. Cytomedix received an upfront payment of...
07:00 , Aug 19, 2013 |  BC Week In Review  |  Financial News

Cytomedix financial update

Cytomedix amended its senior secured credit facility with MidCap Financial to reduce the facility to $4.5 million from $7.5 million. The parties also agreed to an accelerated payment schedule to begin on Sept. 1. Additionally,...